CLINICAL_TRIALS
trial_result
· 2017-08-08
Clinical Trial Update: Tacrobell tab_Phase1_PK [Phase 1]
Summary
Phase 1 pharmacokinetic evaluation of Tacrobell tablets (tacrolimus) sponsored by Chong Kun Dang Pharmaceutical has completed, examining immunosuppressive pharm…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Immunosuppressant(Organ Transplantation, RA) | Phase 1 | Status: COMPLETED